1. Mannuzza S, Klein RG, Bessler A, et al. Adult outcome of hyperactive boys. Educational achievement, occupational rank, and psychiatric status. Arch Gen Psychiatry 1993;50:565-76.
2. Sullivan MA, Rudnik-Levin F. Attention deficit/hyperactivity disorder and substance abuse. Diagnostic and therapeutic considerations. Ann NY Acad Sci 2001;931:251-70.
3. Hunt RD. Nosology, neurobiology, and clinical patterns of ADHD in adults. Psychiatric Ann 1997;27:572-81.
4. Taylor MA. Evaluation and management of attention-deficit hyperactivity disorder. Am Fam Phys 1997;55:887-904.
5. Diller LH. The run on Ritalin. Attention deficit disorder and stimulant treatment in the 1990s. Hasting Center Report 1996;26:12-18.
6. Pincus HA, Tanielian TL, Marcus SC, et al. Prescribing trends in psychotrophic medications: primary care, psychiatry, and other medical specialties. JAMA 1998;279:526-31.
7. Mortan WA, Stockton GG. Methylphenidate abuse and psychiatric side effects. J Clin Psychiatry (Primary Care) 2000;2:159-64.
8. Volkow ND, Ding YS, Fowler JS, et al. Is methylphenidate like cocaine? Studies on their pharmacokinetics and distribution in the human brain. Arch Gen Psychiatry 1995;52:456-63.
9. Banov MD, Palmer T, Brody E. Antidepressants are as effective as stimulants in the long-term treatment of ADHD in Adults. Primary Psychiatry 2001;8:54-7.
10. Moline S, Frankenberger W. Use of stimulant medication for treatment of attention-deficit/hyperactivity disorder. A survey of middle and high school students attitudes. Psychology in the Schools 2001;38:569-84.
11. Prescription drugs: abuse and addiction. National Institute on Drug Abuse Research Report Series. NIH publication number 01-4881, July 2001.
12. Mann A. Illicit methylphenidate trade appears widespread. Clinical Psychiatry News June 2000;28(6):5-
13. ABCNews.com. http://more/abcnews.go.com/sections/living/DailyNews/ritalin0505.html
14. Higgins ES. A comparative analysis of antidepressants and stimulants for the treatment of adults with attention-deficit hyperactivity disorder. J Fam Pract 1999;48:15-20.
15. Arnsten AF, Steere JC, Hunt RD. The contribution of alpha2-noradrenergic mechanisms to prefrontal cortical cognitive function. Arch Gen Psychiatry 1996;53:448-55.
16. DuPaul G. The ADHD Rating Scale: normative data, reliability, and validity. Worcester, MA: University of Massachusetts Medical School, 1990.
17. Wilens TE, Biederman J, Prince J, et al. Six-week, double-blind, placebo-controlled study of desipramine for adult attention-deficit/hyperactivity disorder. Am J Psychiatry 1996;153:1147-53.
18. Spencer T, Wilens T, Biederman J, Faraone SV, Ablon JS, Lapey K. A double-blind, crossover comparison of methylphenidate and placebo in adults with childhood-onset attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 1995;52:434-43.
19. Wilens TE, Spencer TJ, Biederman J, et al. A controlled clinical trial of bupropion for attention-deficit/hyperactivity disorder in adults. Am J Psychiatry 2001;158:282-8.
20. Kuperman S, Perry PJ, Gaffney GR, et al. Bupropion SR vs. methylphenidate vs. placebo for attention-deficit/hyperactivity disorder in adults. Ann Clin Psychiatry 2001;13:129-34.
21. Wooltorton E. Bupropion (Zyban, Wellbutrin SR): reports of death, seizures, serum sickness. Can Med J 2002;166:68.-
22. Upadhyaya HP, Brady KT, Sethuraman G, et al. Venlafaxine treatment of patients with comorbid alcohol/cocaine abuse and attention-deficit/hyperactivity disorder: a pilot study. J Clin Psychopharmacol 2001;21:116-8.
23. Thase ME. Effects of venlafaxine on blood pressure: a meta-analysis of original data from 3744 depressed patients. J Clin Psychiatry 1998;59:502-8.
24. Spencer T, Biederman J, Wilens T, Prince J, Hatch M. Effectiveness and tolerability of tomoxetine in adults with attention-deficit/hyperactivity disorder. Am J Psychiatry 1998;155:693-5.
25. Michelson D, Faries D, Wernicke J, et al. Atomoxetine in the treatment of children and adolescents with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, dose-response study. Pediatrics 2001;108:E83.-
26. Kratochvil C, Heiligenstein JH, Dittmann R, et al. Atomoxetine and methylphenidate treatment in ADHD children: a randomized, open-label trial (presentation). Honolulu: American Academy of Child and Adolescent Psychiatry, October, 2001.
